Production (Stage)
Galera Therapeutics, Inc.
GRTX
$0.027
-$0.0056-17.18%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.17M | -18.96M | -19.61M | -29.11M | -45.75M |
| Total Depreciation and Amortization | 11.00K | 20.00K | 235.00K | 242.00K | 248.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.89M | 8.92M | 7.03M | 6.97M | 12.10M |
| Change in Net Operating Assets | -1.32M | -2.13M | -7.37M | -8.05M | -4.56M |
| Cash from Operations | -9.59M | -12.15M | -19.72M | -29.94M | -37.97M |
| Capital Expenditure | -- | -- | -9.00K | -9.00K | -59.00K |
| Sale of Property, Plant, and Equipment | 4.00K | 4.00K | 4.00K | -- | -- |
| Cash Acquisitions | -50.00K | -50.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 3.98M | 14.45M | 22.05M |
| Cash from Investing | -46.00K | -46.00K | 3.98M | 14.44M | 21.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.86M | 2.22M | -- | 4.54M | 6.35M |
| Repurchase of Common Stock | -- | -- | -2.64M | -2.64M | -2.64M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.40M | 0.00 | 0.00 |
| Cash from Financing | 2.86M | 2.22M | -232.00K | 1.90M | 3.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.78M | -9.97M | -15.97M | -13.60M | -12.27M |